Research Topics
| Katherine A GrossetSummaryCountry: UK Publications
| Collaborators |
Detail Information
Publications
Effect of educational intervention on medication timing in Parkinson's disease: a randomized controlled trialKatherine A Grosset
Department of Neurology, Institute of Neurological Sciences, Southern General Hospital, Glasgow, UK
BMC Neurol 7:20. 2007..The effect of informing Parkinson's disease patients about the continuous dopaminergic hypothesis (to encourage regular medicine intake) on medication adherence and motor control was tested...
Accuracy of Parkinson's disease diagnosis in 610 general practice patients in the West of ScotlandEdward J Newman
Department of Neurology, Institute of Neurological Sciences, Southern General Hospital, Glasgow, UK
Mov Disord 24:2379-85. 2009..Nearly all of these patients can be identified by simple screening of prescription databases and case records in Primary Care, followed by clinical review, which allows withdrawal of unnecessary medication...
Two-year follow-up in 150 consecutive cases with normal dopamine transporter imagingVicky L Marshall
Department of Neurology, Institute of Neurological Sciences, Southern General Hospital, Glasgow, UK
Nucl Med Commun 27:933-7. 2006....- Suboptimal medication adherence in Parkinson's diseaseKatherine A Grosset
Institute of Neurological Sciences, Southern General Hospital, Glasgow, United Kingdom
Mov Disord 20:1502-7. 2005..In conclusion, poorer compliance is associated with younger age, depression, and more tablets per day, and one-fifth of PD patients underuse medication. Consideration of drug therapy adherence has implications in the management of PD... - Medicine-taking behavior: implications of suboptimal compliance in Parkinson's diseaseKatherine A Grosset
Department of Neurology, Institute of Neurological Sciences, Southern General Hospital, Glasgow, United Kingdom
Mov Disord 20:1397-404. 2005..Although the benefits of regularizing oral medicine-taking in a practical, achievable way in PD remain untested, such an approach might prolong and smooth the benefits of oral medication and is worthy of further research... - Patient-perceived involvement and satisfaction in Parkinson's disease: effect on therapy decisions and quality of lifeKatherine A Grosset
Institute of Neurological Sciences, Southern General Hospital, Glasgow, United Kingdom
Mov Disord 20:616-9. 2005..Due attention to these aspects in delivering care to the PD patient is appropriate... - Successful antiparkinsonian medication withdrawal in patients with Parkinsonism and normal FP-CIT SPECTVicky L Marshall
Department of Neurology, Institute of Neurological Sciences, Southern General Hospital, Glasgow, United Kingdom
Mov Disord 21:2247-50. 2006..Such cases represent a nondegenerative form of Parkinsonism, which does not benefit from dopaminergic therapy. Prospective vigilance regarding this category is of importance in clinical practice and clinical trials... - Geographical difference in Parkinson's disease prevalence within West ScotlandEdward J Newman
University of Glasgow, Department of Neurology, Institute of Neurological Sciences, Southern General Hospital, Glasgow, United Kingdom
Mov Disord 24:401-6. 2009..Exploration of these factors is justified to explain further such wide variation in PD prevalence... - Problematic gambling on dopamine agonists: Not such a rarityKatherine A Grosset
Institute of Neurological Sciences, Southern General Hospital, Glasgow, Scotland
Mov Disord 21:2206-8. 2006..Thus, 8% of patients taking dopamine agonists had pathological gambling. Pathological gambling is not uncommon, and patients should be made aware of this potential adverse effect...